Literature DB >> 21854684

Hypothesis-driven candidate genes for schizophrenia compared to genome-wide association results.

A L Collins1, Y Kim, P Sklar, M C O'Donovan, P F Sullivan.   

Abstract

BACKGROUND: Candidate gene studies have been a key approach to the genetics of schizophrenia (SCZ). However, the results of these studies are confusing and no genes have been unequivocally implicated. The hypothesis-driven candidate gene literature can be appraised by comparison with the results of genome-wide association studies (GWAS).
METHOD: We describe the characteristics of hypothesis-driven candidate gene studies from the SZGene database, and use pathway analysis to compare hypothesis-driven candidate genes with GWAS results from the International Schizophrenia Consortium (ISC).
RESULTS: SZGene contained 732 autosomal genes evaluated in 1374 studies. These genes had poor statistical power to detect genetic effects typical for human diseases, assessed only 3.7% of genes in the genome, and had low marker densities per gene. Most genes were assessed once or twice (76.9%), providing minimal ability to evaluate consensus across studies. The ISC studies had 89% power to detect a genetic effect typical for common human diseases and assessed 79% of known autosomal common genetic variation. Pathway analyses did not reveal enrichment of smaller ISC p values in hypothesis-driven candidate genes, nor did a comprehensive evaluation of meta-hypotheses driving candidate gene selection (SCZ as a disease of the synapse or neurodevelopment). The most studied hypothesis-driven candidate genes (COMT, DRD3, DRD2, HTR2A, NRG1, BDNF, DTNBP1 and SLC6A4) had no notable ISC results.
CONCLUSIONS: We did not find support for the idea that the hypothesis-driven candidate genes studied in the literature are enriched for the common genetic variation involved in the etiology of SCZ. Larger samples are required to evaluate this conclusion definitively.

Entities:  

Mesh:

Year:  2011        PMID: 21854684      PMCID: PMC4188923          DOI: 10.1017/S0033291711001607

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  37 in total

Review 1.  Array-based DNA diagnostics: let the revolution begin.

Authors:  Arthur L Beaudet; John W Belmont
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

2.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

3.  Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering.

Authors:  Sharon R Browning; Brian L Browning
Journal:  Am J Hum Genet       Date:  2007-09-21       Impact factor: 11.025

4.  No association of the serotonin transporter polymorphisms 5-HTTLPR and RS25531 with schizophrenia or neurocognition.

Authors:  Thomas I Konneker; James J Crowley; Corey R Quackenbush; Richard S E Keefe; Diana O Perkins; T Scott Stroup; Jeffrey A Lieberman; Edwin van den Oord; Patrick F Sullivan
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-07       Impact factor: 3.568

5.  Rare chromosomal deletions and duplications increase risk of schizophrenia.

Authors: 
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

6.  Genomewide association for schizophrenia in the CATIE study: results of stage 1.

Authors:  P F Sullivan; D Lin; J-Y Tzeng; E van den Oord; D Perkins; T S Stroup; M Wagner; S Lee; F A Wright; F Zou; W Liu; A M Downing; J Lieberman; S L Close
Journal:  Mol Psychiatry       Date:  2008-03-18       Impact factor: 15.992

7.  Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort.

Authors:  Lavinia Athanasiu; Morten Mattingsdal; Anna K Kähler; Andrew Brown; Omar Gustafsson; Ingrid Agartz; Ina Giegling; Pierandrea Muglia; Sven Cichon; Marcella Rietschel; Olli P H Pietiläinen; Leena Peltonen; Elvira Bramon; David Collier; David St Clair; Engilbert Sigurdsson; Hannes Petursson; Dan Rujescu; Ingrid Melle; Vidar M Steen; Srdjan Djurovic; Ole A Andreassen
Journal:  J Psychiatr Res       Date:  2010-02-24       Impact factor: 4.791

8.  NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins.

Authors:  Kim D Pruitt; Tatiana Tatusova; Donna R Maglott
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

9.  Common variants conferring risk of schizophrenia.

Authors:  Hreinn Stefansson; Roel A Ophoff; Stacy Steinberg; Ole A Andreassen; Sven Cichon; Dan Rujescu; Thomas Werge; Olli P H Pietiläinen; Ole Mors; Preben B Mortensen; Engilbert Sigurdsson; Omar Gustafsson; Mette Nyegaard; Annamari Tuulio-Henriksson; Andres Ingason; Thomas Hansen; Jaana Suvisaari; Jouko Lonnqvist; Tiina Paunio; Anders D Børglum; Annette Hartmann; Anders Fink-Jensen; Merete Nordentoft; David Hougaard; Bent Norgaard-Pedersen; Yvonne Böttcher; Jes Olesen; René Breuer; Hans-Jürgen Möller; Ina Giegling; Henrik B Rasmussen; Sally Timm; Manuel Mattheisen; István Bitter; János M Réthelyi; Brynja B Magnusdottir; Thordur Sigmundsson; Pall Olason; Gisli Masson; Jeffrey R Gulcher; Magnus Haraldsson; Ragnheidur Fossdal; Thorgeir E Thorgeirsson; Unnur Thorsteinsdottir; Mirella Ruggeri; Sarah Tosato; Barbara Franke; Eric Strengman; Lambertus A Kiemeney; Ingrid Melle; Srdjan Djurovic; Lilia Abramova; Vasily Kaleda; Julio Sanjuan; Rosa de Frutos; Elvira Bramon; Evangelos Vassos; Gillian Fraser; Ulrich Ettinger; Marco Picchioni; Nicholas Walker; Timi Toulopoulou; Anna C Need; Dongliang Ge; Joeng Lim Yoon; Kevin V Shianna; Nelson B Freimer; Rita M Cantor; Robin Murray; Augustine Kong; Vera Golimbet; Angel Carracedo; Celso Arango; Javier Costas; Erik G Jönsson; Lars Terenius; Ingrid Agartz; Hannes Petursson; Markus M Nöthen; Marcella Rietschel; Paul M Matthews; Pierandrea Muglia; Leena Peltonen; David St Clair; David B Goldstein; Kari Stefansson; David A Collier
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

10.  Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women.

Authors:  Sagiv Shifman; Martina Johannesson; Michal Bronstein; Sam X Chen; David A Collier; Nicholas J Craddock; Kenneth S Kendler; Tao Li; Michael O'Donovan; F Anthony O'Neill; Michael J Owen; Dermot Walsh; Daniel R Weinberger; Cuie Sun; Jonathan Flint; Ariel Darvasi
Journal:  PLoS Genet       Date:  2008-02       Impact factor: 5.917

View more
  39 in total

1.  What is a functional genetic polymorphism? Defining classes of functionality.

Authors:  Paul R Albert
Journal:  J Psychiatry Neurosci       Date:  2011-11       Impact factor: 6.186

Review 2.  Genetic architectures of psychiatric disorders: the emerging picture and its implications.

Authors:  Patrick F Sullivan; Mark J Daly; Michael O'Donovan
Journal:  Nat Rev Genet       Date:  2012-07-10       Impact factor: 53.242

3.  Temperament and externalizing behavior as mediators of genetic risk on adolescent substance use.

Authors:  Elisa M Trucco; Brian M Hicks; Sandra Villafuerte; Joel T Nigg; Margit Burmeister; Robert A Zucker
Journal:  J Abnorm Psychol       Date:  2016-02-04

4.  Testing the role of circadian genes in conferring risk for psychiatric disorders.

Authors:  Enda M Byrne; Andrew C Heath; Pamela A F Madden; Michele L Pergadia; Ian B Hickie; Grant W Montgomery; Nicholas G Martin; Naomi R Wray
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-03-29       Impact factor: 3.568

Review 5.  Genome-wide association studies of schizophrenia: does bigger lead to better results?

Authors:  Sarah E Bergen; Tracey L Petryshen
Journal:  Curr Opin Psychiatry       Date:  2012-03       Impact factor: 4.741

6.  Gene-Environment Interplay: Where We Are, Where We Are Going.

Authors:  Jessica E Salvatore; Danielle M Dick
Journal:  J Marriage Fam       Date:  2015-04

7.  Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition.

Authors:  Claudia J P Simons; Ruud van Winkel
Journal:  Schizophr Bull       Date:  2012-04-24       Impact factor: 9.306

Review 8.  Genetic influences on conduct disorder.

Authors:  Jessica E Salvatore; Danielle M Dick
Journal:  Neurosci Biobehav Rev       Date:  2016-06-24       Impact factor: 8.989

Review 9.  The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research.

Authors:  Conrad Iyegbe; Desmond Campbell; Amy Butler; Olesya Ajnakina; Pak Sham
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-01-17       Impact factor: 4.328

Review 10.  Bringing a developmental perspective to anxiety genetics.

Authors:  Lauren M McGrath; Sydney Weill; Elise B Robinson; Rebecca Macrae; Jordan W Smoller
Journal:  Dev Psychopathol       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.